Study sheds light on the high burden of late effects among young survivors of acute myeloid leukemia - Earth News Report
Reviewed by Emily Henderson, B.Sc.Nov 9 2020 Adolescent and young adult (AYA) patients treated for acute myeloid leukemia (AML) have a high risk of developing several long-term health complications, a study led by UC Davis Comprehensive Cancer Center researchers has found. The most common complications among AYA survivors (ages 15–39) were cardiovascular, endocrine and respiratory
